Trump, who leaves office on Jan. 20 after losing November's election to President-elect Joe Biden, backed down from his earlier threat to block the bill.
"Much more money is coming," he insisted in a statement, though he provided nothing to back this promise.
Argentina's 2020/21 soybean planting area could turn out to be smaller than the projected 17.2 million hectares due to unusually dry weather, the Buenos Aires Grains Exchange said in its weekly crop report on Wednesday.
In an unusual twist, the man who prosecuted Charles Kushner was Chris Christie, now the former governor of New Jersey, who also has served as an adviser to Trump.
The metal managed to stabilize around a support at $1,862, the 38.2% projection level of an upward wave c from $1,862. This wave may have completed around $1,904.
Underscoring the economic hit from the pandemic, data on Wednesday showed elevated US jobless claims and a drop in consumer spending for the first time since May in November.
The pan-European STOXX 600 index finished up 1.2% on broad-based gains, recovering from a more than 2% slide in the previous session, which was also its biggest one-day drop in nearly two months.
The package includes $892 billion for coronavirus relief plus federal government funding to also avert a government shutdown - together worth about $2.3 trillion.
The wide-ranging bill includes $600 payments to most Americans and additional money to the millions of people thrown out of work during the COVID-19 pandemic.
The 6-3 ruling on ideological lines, with the court’s six conservatives in the majority and three liberals dissenting, gives Trump a short-term victory.
Some of Trump’s political appointees in the defense department have recently stopped cooperating, Yohannes Abraham, the executive director of Biden’s transition team said.
U.S. S&P 500 E-minis were up 1 point, or 0.03pc at 8:06 a.m. ET, Dow E-minis were up 6 points, or 0.02pc, while Nasdaq 100 E-minis were up 2.25 points, or 0.02pc.
The Food and Drug Administration is expected to issue formal approval Friday. This would make Moderna's vaccine the second to be approved in a Western country following the one developed by Pfizer-BioNTech.